B. Metzler Seel. Sohn & Co. Ag Lantheus Holdings, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 19,367 shares of LNTH stock, worth $1.59 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,367
Previous 14,043
37.91%
Holding current value
$1.59 Million
Previous $1.13 Million
88.55%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LNTH
# of Institutions
539Shares Held
69.9MCall Options Held
651KPut Options Held
459K-
Black Rock Inc. New York, NY8.6MShares$704 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$593 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$294 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.96MShares$242 Million1.63% of portfolio
-
State Street Corp Boston, MA2.52MShares$206 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.63B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...